Patent No. 597060 Disclosed is a pharmaceutical composition for the treatment of benign prostate hyperplasia； the pharmaceutical composition comprising 9 mg to 40 mg degarelix or pharmaceutically acceptable salt thereof； and a solvent； wherein the concentration of degarelix or salt thereof in the solvent is from 35 to 45 mg/mL. Also disclosed are a kit and a method of preparing said composition.
